HUM

Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana is expected to release its third-quarter earnings next month, and analysts anticipate a triple-digit decline in its bottom line.

Humana just posted its Q3 2026 scorecard and the headline is simple. Profit swung back to a solid quarter with basic earnings per share of 2.59 SEK on revenue of 2,595 million SEK.

HUM's surging premiums, Medicare Advantage growth and CenterWell expansion bolster its prospects, but rising benefit costs and expenses pose challenges.

The insurer is the first in the country to earn this designation. WASHINGTON, Oct.

Humana announced a joint venture with HPS Investment Partners, part of BlackRock, to manage nearly 150 CenterWell Senior Primary Care clinics, with BlackRock acquiring WCAS’s equity stake valued at about US$2.8b and Humana expecting reduced balance sheet…

Humana (NYSE:HUM) has formed a new joint venture with BlackRock's HPS Investment Partners to operate CenterWell senior primary care clinics.

When payers end a plan, they either want to lose those customers altogether or get those customers to switch to a different, typically pared down and more profitable plan, Brooks Conway, a principal at Oliver Wyman actuarial consulting, told Healthcare Brew.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.

When Humana sends a plan-exit notice this fall, most members will scan it for a replacement option and move on. But buried in that letter is a federal right with an expiration date that could matter far more than any plan Humana offers instead.

HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.